Pablo G. Legorreta, CEO, Chairman of the Board at Royalty Pharma plc (RPRX), bought 130,000 shares at $29.51 ($3.8M) on 2023-06-28, disclosed to the SEC on 2023-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| Filing → |
| RPRX | BUY | 2023-05-24 | $4.8M | — | Filing → |
| RPRX | BUY | 2023-05-17 | $15.4M | — | Filing → |
| RPRX | BUY | 2020-06-22 | $280K | — | Filing → |